Apoptosis

Apoptosis

Cell membrane blebbing, chromatin condensation, genomic DNA fragmentation, and the exposure of particular phagocytosis signaling molecules on the cell surface are just a few of the distinctive morphological and biochemical features of the cell death process known as apoptosis. Apoptosis-initiated cell death is distinct from necrosis-induced cell death. Apoptotic death, in contrast, is silent and orderly. Necrotic cells are typically recognized as a danger signal by the immune system, which causes inflammation.

There are two main methods for inducing apoptotic cell death: The intrinsic pathway, also known as the Bcl-2-regulated or mitochondrial pathway, is strictly regulated by the BCL-2 family of proteins and is activated by a variety of developmental cues or cytotoxic insults, such as viral infection, DNA damage, and growth-factor deprivation.The tumor necrosis factor (TNF) receptor family members, such as Fas or TNF receptor-1 (TNFR1), which contain an intracellular death domain and can recruit and activate caspase-8 through the adaptor protein Fas-associated death domain (FADD; also known as MORT1) at the cell surface, are what initiate the extrinsic or death-receptor pathway. Without the involvement of the BCL-2 family, this recruitment results in the subsequent activation of downstream (effector) caspases like caspase-3, -6, or -7.

Numerous human diseases, including cancer, viral infections, autoimmune diseases, neurodegenerative disorders, and AIDS (acquired immunodeficiency syndrome), may be influenced by changes in cell survival, according to studies. Some of these diseases may not progress naturally unless specific therapies that change the apoptotic threshold are used.

Apoptosis related products

Structure Cat No. Product Name CAS No. Product Description
V52489 6,8-Diprenylorobol (6,8-Diprenylcoupeagen) 66777-70-6 6,8- diprenylorobol is an enoylated isoflavone, a naturally occurring compound extracted from the leaves of Cudrania tricuspidata.
V52485 6-Dehydrogingerdione 76060-35-0 6-Dehydrogingerdione sensitizes human hepatoblastoma Heg2 cells to TRAIL-induced apoptosis through the increase of DR5 mediated by reactive oxygen species.
V52482 6-Formylpterin 712-30-1 6-Formylpterin is an inhibitor (blocker/antagonist) of Xanthine Oxidase.
V54837 7,3′,5′-Trihydroxyflavanone 847375-46-6 7,3′,5′-Trihydroxyflavanone is a flavonoid analogue that can cause apoptosis in MCF-7 cells by increasing Bax expression levels.
V54858 7-epi-Isogarcinol 1141378-40-6 7-epi-Isogarcinol is a polycyclic polyprenoylphloroglucinol (PPAP) with moderate antiproliferation activity.
V54853 7-Ketositosterol 2034-74-4 7-Ketositosterol is a phytosterol extracted from the fruits of the mulberry tree (Morus alba L.).
V52478 7-Methoxy-1-tetralone 6836-19-7 7-Methoxy-1-tetralone is a potent antineoplastic/anticancer agent.
V52469 8-Aminoadenosine (8-Aminoadenosine; 8-NH2-Ado) 3868-33-5 8-Aminoadenosine (8-NH2-Ado) is an RNA-directed nucleoside analog that reduces cellular ATP levels and inhibits mRNA synthesis.
V52472 8-Epixanthatin 30890-35-8 8-Epixanthatin is a potential colchicine binding site inhibitor extracted from Xanthium chinese Mill.
V52475 84-B10 698346-43-9 84-B10 is a 3-phenylglutaric acid analogue.
V54927 A-1293102 1565759-96-7 A-1293102 is a potent and specific BCL-XL inhibitor that kills BCL-XL-dependent tumor cells.
V77704 A-71915 TFA A-71915 (TFA) is a selective atrial natriuretic peptide receptor (ANP receptor) inhibitor that can cause apoptosis of RINm5F pancreatic β-cells and reduce insulin secretion.
V54941 A09-003 2911646-14-3 A09-003 is a CDK-9 inhibitor (IC50= 16 nM).
V52462 A947 2378056-80-3 A947 is a potent and specific SMARCA2 proteolytically targeting chimeric molecule (PROTAC).
V52460 AAF-CMK 102129-66-8 AAF-CMK is a TPPII (tripeptidylpeptidase II) inhibitor that has anti-tumor activity and causes apoptosis.
V52663 Abacavir-d4 (Abacavir d4) 1260619-56-4 Abacavir-d4 is the deuterium labelled form of Abacavir.
V53116 ABBV-167 1351456-78-4 ABBV-167 is a phosphate precursor of the BCL-2 inhibitor venetoclax.
V54884 ABL-L 1613152-39-8 ABL-L causes apoptosis in human laryngeal cancer/tumor cells through a p53-dependent pathway.
V9987 ABT-510 TFA salts 251579-55-2 ABT-510 TFA, the trifluoroacetic acid (TFA) salt form of ABT-510 which is a TSP-1 mimetic drug,is a synthetic peptide composed of nine-amino acids, it acts bymimicking the anti-angiogenic activity of the endogenous protein thrombospondin-1 (TSP-1).
V54963 Ac-AAVALLPAVLLALLAP-DEVD-CHO (DEVD-CHO-CPP 32) 201608-15-3 Ac-AAVALLPAVLLALLAP-DEVD-CHO (DEVD-CHO-CPP 32) is a potent and reversible caspase-3 inhibitor.
Contact Us Back to top